ATEM Capital
ATEM Capital is a New York-based venture capital firm founded in 2014 that specializes in early, late-stage, and growth capital investments within the life sciences sector. The firm primarily targets the biotechnology and pharmaceuticals fields, allocating 70% of its investments to these areas, which includes a focus on early-stage and late-stage assets. Additionally, it invests in de-risked medical devices and diagnostics, accounting for the remaining 30% of its portfolio. ATEM Capital is particularly interested in life-saving and life-changing technologies, including those related to oncology, cardiovascular health, anti-infectives, CNS/pain management, and women's health. The firm focuses its investment efforts in the United States and Western Europe, targeting companies with market capitalizations under $300 million and listed on major stock exchanges. ATEM Capital also engages in direct co-investments.
Triumvira Immunologics is an immunotherapy company focused on developing innovative T cell therapies for cancer treatment. Founded in 2015 and headquartered in Austin, Texas, with research facilities in Hamilton, Canada, the company specializes in chimeric antigen receptor (CAR) and engineered T cell receptor (TCR) therapies. Its proprietary T cell Antigen Coupler (TAC) technology enhances the natural T cell receptor's capabilities and operates independently of the major histocompatibility complex. This unique approach aims to create more effective therapies for a diverse group of patients suffering from both solid and liquid tumors, as well as other diseases. Triumvira's commitment to advancing cancer treatment reflects its mission to improve patient outcomes with safer and more effective therapeutic options.
Iridia, Inc. is a nanotechnology company based in Carlsbad, California, focused on developing innovative DNA-based data storage solutions. Founded in 2016, Iridia combines expertise in biochemistry, molecular biology, and semiconductor fabrication to create a groundbreaking read and write data storage hard drive that utilizes DNA for long-term data retention. By leveraging DNA polymer synthesis technology and electronic nano-switches, the company aims to achieve exceptionally high-density data storage through a highly-parallel format that includes an array of nanomodules. Formerly known as Dodo OmniData, Inc., Iridia rebranded in March 2018 to reflect its commitment to advancing data storage technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.